Abstract:Protein aggregation is a widespread phenomenon implicated in debilitating diseases like Alzheimer's, Parkinson's, and cataracts, presenting complex hurdles for the field of molecular biology. In this review, we explore the evolving realm of computational methods and bioinformatics tools that have revolutionized our comprehension of protein aggregation. Beginning with a discussion of the multifaceted challenges associated with understanding this process and emphasizing the critical need for precise predictive tools, we highlight how computational techniques have become indispensable for understanding protein aggregation. We focus on molecular simulations, notably molecular dynamics (MD) simulations, spanning from atomistic to coarse-grained levels, which have emerged as pivotal tools in unraveling the complex dynamics governing protein aggregation in diseases such as cataracts, Alzheimer's, and Parkinson's. MD simulations provide microscopic insights into protein interactions and the subtleties of aggregation pathways, with advanced techniques like replica exchange molecular dynamics, Metadynamics (MetaD), and umbrella sampling enhancing our understanding by probing intricate energy landscapes and transition states. We delve into specific applications of MD simulations, elucidating the chaperone mechanism underlying cataract formation using Markov state modeling and the intricate pathways and interactions driving the toxic aggregate formation in Alzheimer's and Parkinson's disease. Transitioning we highlight how computational techniques, including bioinformatics, sequence analysis, structural data, machine learning algorithms, and artificial intelligence have become indispensable for predicting protein aggregation propensity and locating aggregation-prone regions within protein sequences. Throughout our exploration, we underscore the symbiotic relationship between computational approaches and empirical data, which has paved the way for potential therapeutic strategies against protein aggregation-related diseases. In conclusion, this review offers a comprehensive overview of advanced computational methodologies and bioinformatics tools that have catalyzed breakthroughs in unraveling the molecular basis of protein aggregation, with significant implications for clinical interventions, standing at the intersection of computational biology and experimental research.

Morphological features and types of aggregated structures

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Protein aggregation: An overview

Mechanisms and pathology of protein misfolding and aggregation

Aggregation mechanisms and molecular structures of amyloid‐β in Alzheimer's disease

Experimental techniques for detecting and evaluating the amyloid fibrils

Pathways of amyloid fibril formation and protein aggregation

What Does Evolution Tell Us About The Structure Of A Functional Amyloid Protein?

Factors influencing amyloid fibril formation

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Amyloids, amorphous aggregates and assemblies of peptides – Assessing aggregation

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

The role of α-sheet structure in amyloidogenesis: characterization and implications

Amyloid Aggregation: Role of Biological Membranes and the Aggregate-Membrane System

Intrinsic conformational preference in the monomeric protein governs amyloid polymorphism

Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation

Amyloids: friend or foe?

Understanding the Twisted Structure of Amyloid Fibrils Via Molecular Simulations

Advanced computational approaches to understand protein aggregation

Mechanistic Insights and Future Challenges